Prevention of neutrophil extravasation by α2-Adrenoceptor-mediated endothelial stabilization

Journal of Immunology

Volumn 193, Issue 6, 2014, Pages 3023-3035

  Herrera García, Ada María ^a   Domínguez Luis, María Jesús ^a   Arce Franco, María ^b   Armas González, Estefanía ^a   De La Rosa, Diego Álvarez ^c   Machado, José David ^c   Pec, Martina K ^a   Feria, Manuel ^c   Barreiro, Olga ^d   Sánchez Madrid, Francisco ^d,e   Díaz González, Federico ^a,b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d CSIC   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; BETA CATENIN; CD11B ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PLAKOGLOBIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; 2-METHOXYIDAZOXAN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CADHERIN; IDAZOXAN; LEUKOCYTE ANTIGEN; QUINOXALINE DERIVATIVE; THIOGLYCOLIC ACID DERIVATIVE; XYLAZINE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LEUKOCYTE FUNCTION AND CHARACTERISTICS; MALE; MOUSE; NEUTROPHIL EXTRAVASATION; NONHUMAN; PERITONITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; NEUTROPHIL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VASCULAR ENDOTHELIUM;

ADHERENS JUNCTIONS; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD11B; BETA CATENIN; CADHERINS; ENDOTHELIUM, VASCULAR; GAMMA CATENIN; HUMANS; IDAZOXAN; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; MALE; MICE; NEUTROPHILS; PERITONITIS; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; THIOGLYCOLATES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; XYLAZINE; ZYMOSAN;

EID: 84907082120     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400255     Document Type: Article

References (68)

1. Bylund, D. B., D. C. Eikenberg, J. P. Hieble, S. Z. Langer, R. J. Lefkowitz, K. P. Minneman, P. B. Molinoff, R. R. Ruffolo, Jr., and U. Trendelenburg. 1994. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46: 121-136
2. Phili pp, M., M. Brede, and L. Hein. 2002. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R287-R295
3. Korn, S. H., E. F. Wouters, G. Wesseling, J. W. Arends, and F. B. Thunnissen. 1998. Interaction between glucocorticoids and beta2-agonists: alpha and beta glucocorticoid-receptor mRNA expression in human bronchial epitheli al cells. Biochem. Pharmacol. 56: 1561-1569
4. Eickelberg, O., M. Roth, R. Lörx, V. Bruce, J. Rüdiger, M. Johnson, and L. H. Block. 1999. Ligand-independent activation of the glucocorti coid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J. Biol. Chem. 274: 1005-1010
5. Verghese, M. W., R. T. McConnell, A. B. Strickland, R. C. Gooding, S. A. Stimpson, D. P. Yarnall, J. D. Taylor, and P. J. Furdon. 1995. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J. Pharmacol. Exp. Ther. 272: 1313-1320
6. Straub, R. H., C. Günzler, L. E. Miller, M. Cutolo, J. Schölmerich, and S. Schill. 2002. Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rhe umatoid arthritis synovial tissue in vivo and in vitro. FASEB J. 16: 993-1000
7. Pauwels, R. A., C. G. Lö fdahl, D. S. Postma, A. E. Tattersfield, P. O'Byrne, P. J. Barnes, and A. Ullman, Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. 1997. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337: 1405-1411.
8. Derian C.K.,R.J. Santulli,P.E. Rao,H.F. Solomon,J.A. Barrett, 1995, Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators, J. Immunol, 154, 308-317.
9. Nishina, K., H. Akamatsu, K. Mikawa, M. Shiga, N. Maekawa, H. Obara, and Y. Niwa. 1999. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth. Analg. 88: 452-458
10. Titinchi, S., and B. Clark. 1984. Alpha 2-adrenoceptors in human lymphocytes: direct characterisation by [3H]yohimbine binding. Biochem. Biophys. Res. Commun. 121: 1-7
11. Angus , J. A., T. M. Cocks, and K. Satoh. 1986. The alpha adrenoceptors on endothelial cells. Fed. Proc. 45: 2355-2359
12. Benedetto, N., A. Folgore, C. Ferrara, M. Molitierno, and F. Galdiero. 1997. Effects of alpha-adrenergic agonists on Toxoplasma gondii replication in human umbilical vein endothelial cells. Pathol. Biol. 45: 9-18
13. Abraham, E., D. J. Kaneko, and R. Shenkar. 1999. Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am. J. Physiol. 276: L1-L8
14. Stjä rne, P., C. Agusti, L. O. Cardell, S. Wagstaff, and J. A. Nadel. 1997. A method for canine nasal mucosa superfusion, in vivo; evidence that pseudomonas-induced neutrophil migration is inhibited by alpha2-adrenoceptor agonist. Clin. Exp. Allergy 27: 1471-1476
15. Yoon, S. Y., H. W. Kim, D. H. Roh, Y. B. Kwon, H. J. Han, A. J. Beitz, and J. H. Lee. 2006. Intrathecal clonidine suppresses zymosan-induced peripheral leukocyte migration in a mouse air pouch model via activation of spinal mus carinic type 2 receptors and sympathoadrenal medullary activity. Neuropharmacology 51: 829-837
16. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314
17. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036
18. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101
19. Barreiro, O., H. de la Fuente, M. Mittelbrunn, and F. Sá nchez-Madrid. 2007. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol. Rev. 218: 147-164
20. Vestweber, D. 2008. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 28: 223-232
21. Gó mez-Gaviro, M. V., C. Domínguez-Jiménez, J. M. Carretero, P. Sabando, I. González-Alvaro, F. Sánchez-Madrid, and F. Díaz-Gonzá lez. 2000. Downregulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: role of intracellular ATP concentration. Blood 96: 3592-3600
22. Lacal, P., R. Pulido, F. Sánchez-Madrid, and F. Mollinedo. 1988. Intracellular location of T200 and Mo1 glycoproteins in human neutrophils. J. Biol. Chem. 263: 9946-9951
23. Yán? ez-Mó, M., A. Alfranca, C. Caban?as, M. Marazuela, R. Tejedor, M. A. Ursa, L. K. Ashman, M. O. de Landázuri, and F. Sá nchez-Madrid. 1998. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at e ndothelial lateral junctions. J. Cell Biol. 141: 791-804
24. Gá lvez, B. G., S. Matías-Román, J. P. Albar, F. Sánchez-Madrid, and A. G. Arroyo. 2001. Membrane type 1-matrix metalloprotein ase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J. Biol. Chem. 276: 37491-37500
25. Kwon, Y. B., H. W. Kim, T. W. Ham, S. Y. Yoon, D. H. Roh, H. J. Han, A. J. Beitz, I. S. Yang, and J. H. Lee. 2003. The anti-inflammatory effect of bee venom stimulation in a mouse air pouch model is mediated by adrenal medullary activity. J. Neuroendocrinol. 15: 93-96
26. Melnicoff, M. J., P. K. Horan, and P. S. Morahan. 1989. Kinetics of changes in peritoneal cell populations following acute inflammation. Cell. Immunol. 118: 178-191
27. Cook, A. D., E. L. Braine, and J. A. Hamilton. 2003. The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J. Immunol. 171: 4816-4823
28. L ee, A., M. K. Whyte, and C. Haslett. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54: 283-288.
29. Lee D.,J. B. Schultz,P. A. Knauf,M. R, King, 2007. Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl Lewis x under flow. J. Biol. Chem, 282, 4812-4820.
30. Siess, W., and E. G . Lapetina. 1989. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation: a novel synergism. Biochem. J. 263: 377-385
31. Blaxall, H. S., N. A. Hass, and D. B. Bylund. 1994. Expression of alpha 2-adrenergic receptor genes in rat tissues. Receptor 4: 191-199
32. Gyires, K., Z. S. Zá dori, N. Shujaa, R. Minorics, G. Falkay, and P. Mátyus. 2007. Anal ysis of the role of central and peripheral alpha2-adrenoceptor subtypes in gastric mucosal defense in the rat. Neurochem. Int. 51: 289-296
33. Krone, W., D. Müller-Wieland, and H. Greten. 1985. Effects of adrenergic antihypertensive drugs on sterol synthesis in freshly isolated human mononuclear leukocytes. J. Cardiovasc. Pharmacol. 7: 1134-1137
34. Vanhoutte, P. M. 2001. Endothelial adrenoceptors. J. Cardiovasc. Pharmacol. 38: 796-808
35. Panosian, J. O., and G. V. Marinetti. 1983. alpha 2-Adrenergic receptors in human polymorphonuclear leukocyte membranes. Biochem. Pharmacol. 32: 2243-2247
36. Musgrave, I. F., and R. Seifert. 1994. Human neutrophils and HL-60 cells do not possess alpha 2-adrenoceptors. Biochem. Pharmacol. 47: 233-239
37. Cantor, L. B. 2000. The evolvin g pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use. Expert Opin. Pharmacother. 1: 815-834
38. Clarke, R. W., and J. Harris. 2002. RX 821002 as a t ool for physiological investigation of alpha(2)-adrenoceptors. CNS Drug Rev. 8: 177-192
39. Mahadeo, D. C., M. Janka-Junttila, R. L. Smoot, P. Roselova, and C. A. Parent. 2007. A chemoattractant-mediated Gi-coupled pathway activates adenylyl cyclase in human neutrophils. Mol. Biol. Cell 18: 512-522
40. Deupree, J. D., W. J. Burke, and D. B. Bylund. 2008. Alpha-2 adrenergicinduced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration. BMC Pharmacol. 8:17
41. Filep, J. G., and D. El Kebir. 2009. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. J. Cell. Biochem. 108: 1039-1046
42. Shen, S. G., D. Zhang, H. T. Hu, J. H. Li, Z. Wang, and Q. Y. Ma. 2008. Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro. World J. Gastroenterol. 14: 2358-2363
43. Uchida-Oka, N., and M. Sugimoto. 2001. Norepinephrine induces apoptosis in skin melanophores by attenuating cAMP-PKA signals via alpha2-adrenoceptors in the medaka, Oryzias latipes. Pigment Cell Res. 14: 356-361
44. Kishikawa, H., K. Ko bayashi, K. Takemori, T. Okabe, K. Ito, and A. Sakamoto. 2008. The effects of dexmedetomidine on human neutrophil apoptosis. Biomed. Res. 29: 189-194
45. Hughes, P. E., and M. Pfaff. 1998 . Integrin affinity modulation. Trends Cell Biol. 8: 359-364
46. Zeilhofer, H. U., and W. Schorr. 2000. Role of interleukin-8 in neutrophil signaling. Curr. Opin. Hematol. 7: 178-182.
47. Diamond, M. S., and T. A. Springer. 1993. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120: 545-556
48. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-434
49. von Andrian, U. H., J. D. Chambers, E. L. Berg, S. A. Michie, D. A. Brown, D. Karolak, L. Ramezani, E. M. Berger, K. E. Arfors, and E. C. Butcher. 1993. L-selectin mediates neutrophil rolling in inflamed venules through sialyl LewisX-dependent and-independent recognition pathways. Blood 82: 182-191.
50. Alcaide P.,S. Auerbach,F. W, Luscinskas, 2009, Neutrophil recruitment under shear flow: it's all about endothelial cell rings and gaps. Microcirculation, 16, 43-57.
51. Alli ngham, M. J., J. D. van Buul, and K. Burridge. 2007. ICAM-1-mediated, Srcand Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J. Immunol. 179: 4053 -4064
52. Fukuhara, S., A. Sakurai, H. Sano, A. Yamagishi, S. Somekawa, N. Takakura, Y. Saito, K. Kangawa, and N. Mochizuki. 2005. Cyclic AMP potentiates vascular endothelial cadherin-mediate d cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25: 136-146
53. McCune, S. K., M. M. Voigt, and J. M. Hill. 1993. Expression of m ultiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience 57: 143-151
54. Nicholas, A. P., T. Hö kfelt, and V. A. Pieribone. 1996. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol. Sci. 17: 245-255
55. Felsner, P., D. Hofer, I. Rinner, S. Porta, W. Korsatko, and K. Schauenstein. 1995. Adrenergic suppress ion of peripheral blood T cell reactivity in the rat is due to activation of peripheral alpha 2-receptors. J. Neuroimmunol. 57: 27-34
56. Maes, M., A. Lin, G. Kenis, B. Egyed, and E. Bosmans. 2000. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res. 96: 245-253
57. Vanhoutte, P. M., and V. M. Miller. 1989. Alpha 2-adrenoceptors and endothelium-derived relaxing factor. Am. J. Med. 87: 1S-5S
58. Sanders, V. M. 2012. The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav. Immun. 26: 195-200.
59. Casale, T. B., and M. Kaliner. 1984. Demonstration that circulating human blood cells have no detectable alpha 1-adrenergic receptors by radioligand binding analysis. J. Allergy Clin. Immunol. 74: 812-818.
60. Aantaa, R., A. Marjamä ki, and M. Scheinin. 1995. Molecular pharmacology of alpha 2-adrenoceptor subtypes. Ann. Med. 27: 439-449
61. Garrido-Urbani, S., P. F. Bradfield, B. P. Lee, and B. A. Imhof. 2008. Vascular and epithelial junctions: a barrier for leucocyte migration. Biochem. Soc. Trans. 36: 203-211
62. Horn, N. A., D. M. Anastase, K. E. Hecker, J. H. Baumert, T. Robitzsch, and R. Rossaint. 2005. Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro. Anesth. Analg. 100: 520-526
63. Díaz-González, F., and F. Sá nchez-Madrid. 1998. Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs. Immunol. Today 19: 169-172
64. Ginsberg, M. H., and F. Díaz-Gonzá lez. 1997. Cell adhesion molecules and endothelial cells in arthritis. In Arthritis and Allied Conditions: A Textbook of Rheumatology, 13th Ed. W. J. Koopman, ed. Williams and Wilkins, Baltimore, MD, p. 479-489
65. Kimoto, T., M. Takanashi, H. Mukai, K. Ogawara, T. Kimura, and K. Higaki. 2009. Effect of adrenergic stimulation on drug absorption via passive diffusion in Caco-2 cells. Int. J. Pharm. 368: 31-36
66. Lampugnani, M. G., M. Resnati, M. Raiteri, R. Pigott, A. Pisacane, G. Houen, L. P. Ruco, and E. Dejana. 1992. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell B iol. 118: 1511-1522
67. Gavard, J. 2009. Breaking the VE-cadherin bonds. FEBS Lett. 583: 1-6
68. Vestweber, D. 2007. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 218: 178-196